$ATGL

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday. Shares of Helmerich and Payne Inc ( NYSE:HP ) fell sharply in pre-market trading after the company reported fourth-quarter financial results.

Original reporting
Benzinga · Avi Kapoor
Published Nov 18, 2025, 1:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 18, 2025, 2:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC) — source image
Decision brief

The 30-second read

$ATGLBullishMed
01

Why it matters

The earnings report from HP triggered a pre-market decline, while ATGL's positive sentiment suggests company-specific factors or recent news are influencing its stock.

02

Market read

The news highlights sector-specific movements within the context of a broader market downturn, with mixed impacts across different stocks and sectors.

03

What to watch

Potential positive developments in HP's upcoming projects or sector-wide recovery signals could offset current negative sentiment.

Timing: short-term (next 1-3 trading days)

Background

The broader market experienced a decline, with specific weakness in energy and industrial sectors, influenced by macroeconomic factors.

Company-level read

Ticker impact

$ATGLBullishMedium confidence
Context

The stock of Alpha Technology Group (NASDAQ:ATGL) is directly mentioned in the news, with a somewhat bullish sentiment.

Expected impact

Potential short-term upward movement of approximately 2-4%, contingent on broader market stability.

Evidence & confidence

The positive sentiment score and the stock's somewhat bullish sentiment suggest a modest upward bias; however, overall market weakness tempers confidence.

$HPBearishHigh confidence
Context

Helmerich and Payne Inc (NYSE:HP) is highlighted as moving lower after earnings, with a somewhat bearish sentiment.

Expected impact

Expected further decline of 3-5% in the short term, especially if technical support levels are breached.

Evidence & confidence

Earnings miss and pre-market decline support a bearish outlook, with technical analysis likely confirming downward momentum.

$FULCNeutralLow confidence
Context

Fulcrum Therapeutics (NASDAQ:FULC) is mentioned with a neutral sentiment, indicating limited immediate impact.

Expected impact

Likely negligible price movement, within a 1-2% range.

Evidence & confidence

The neutral sentiment and low relevance imply limited influence on the stock's short-term price.

Market effects

Energy & Transportation sector may experience continued pressure due to broader market declines; Technology sector shows resilience in select stocks.

Limited regional impact; primarily U.S. market focus.

Low; the news pertains mainly to U.S. stocks and sectors.

Counterpoint

The decline in HP may be overdone if earnings were temporarily weak; a rebound could occur if broader market sentiment improves.

Key entities

  • Helmerich and Payne Inc

    A provider of contract drilling services for the oil and gas industry.

  • Alpha Technology Group

    A technology firm listed on NASDAQ, involved in innovative tech solutions.

Related articles

$HPMed

Helmerich & Payne (NYSE:HP) Reports Upbeat Q2 CY2026

Helmerich & Payne (NYSE:HP) reported Q2 CY2026 results. Revenue was $1.03 billion, flat year on year but 5.4% above Wall Street estimates. GAAP profit was $0.74 per share, above analysts’ consensus. The article also cites adjusted EBITDA margin of 22.8% and notes the stock was about $33.59 after results.

$HPMed

Helmerich & Payne, Inc. (HP): Results of Operations and Financial Condition

Helmerich & Payne, Inc. (HP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26earningsrelease.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE August 5, 2026 HELMERICH & PAYNE, INC. ANNOUNCES FISCAL THIRD QUARTER RESULTS Operating and Financial Highlights for the Quarter Ended June 30, 2026 • H&P announced consolidated revenue of $1.035 billi

$FULCHighAI 10/10

FULC Stock Crashes After Hours: What Investors Need To Know - Fulcrum Therapeutics (NASDAQ:FULC)

Fulcrum Therapeutics (NASDAQ:FULC) shares fell 49.69% to $3.23 in after-hours after the company said it is discontinuing pociredir for sickle cell disease, citing FDA concerns about the benefit-risk profile linked to malignancy risks seen with Tazverik. Fulcrum also launched a strategic alternatives review and plans to cut expenses. It reported $333.3 million in cash as of March 31, 2026.

$HPMedAI 8/10

BofA Raises its Price Target on Helmerich & Payne (HP)

On May 19, 2026, BofA analyst Saurabh Pant raised Helmerich & Payne’s (HP) price target to $44 from $41 and kept a Buy rating, citing updated oilfield services models after Q1 earnings and 10-Q filings. BofA said 2027 and 2028 EBITDA forecasts are about 10% and 16% above consensus. Piper Sandler raised its target to $43 from $41 with an Overweight rating.